Clinical Trial Update: Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of SST-6007 topical sildenafil cream versus placebo in women with Female Sexual Arousal Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder

Drugs mentioned

• SST-6007 (sildenafil)

Snippet

Sponsor: Strategic Science & Technologies, LLC | Conditions: Sexual Arousal Disorder | Phase 2 | Status: COMPLETED